Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Post by helpline88on Jun 04, 2024 5:29pm
215 Views
Post# 36072050

Interesting news article

Interesting news articleOn page 2 of todays Province Newspaper there is the following headline "Vancouver firm gets permission to export Psilocybin for medical use". The company name is Optimi Health Corp. co founded by John James Wilson, son of Lululemon Chip Wilson. Nice to have a billionare father who no doubt is helping his son. It appears Optimi is producing Psilocybin by growing their own mushrooms so not synthetic like what Core One produces. Optimi will be exporting to Australia for patient use and they believe the demand for Psilocybin will be robust. Optimi is a startup and its very early for them. A significant investment to get going. 

No news from Core. Shares just keep trading lower. I thought Core had an advantage in this sector but I guess not. 
<< Previous
Bullboard Posts
Next >>